Get started
Boston Scientific CorporationBoston Scientific CorporationBoston Scientific Corporation

Boston Scientific Corporation

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFsBonds
Full chart
Full chart

Compare with Boston Scientific Corporation



Key stats


Market capitalization
‪71.45 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
19.99
Basic EPS (TTM)
2.48 USD
Net income (FY)
‪2.90 B‬ USD
Revenue (FY)
‪20.07 B‬ USD
Shares float
‪1.44 B‬
Beta (1Y)
0.31

Latest earnings


Last report date
Jul 29, 2026
Report period
Q2 2026
EPS
0.86 USD
Revenue
‪5.44 B‬ USD
Earnings call summary

Q2 2026 saw 7% organic sales growth and 15% adjusted EPS growth, exceeding guidance. Full-year 2026 outlook was revised down due to WATCHMAN and EP headwinds, with organic revenue now expected to grow 5%-6% and adjusted EPS 7%-8%. Restructuring and new launches are set to drive recovery by 2028.

Employees


Employees (FY)
‪59 K‬
Change (1Y)
‪+6 K‬+11.32%
Revenue / Employee (1Y)
‪340.24 K‬ USD
Net income / Employee (1Y)
‪49.12 K‬ USD

Details


Sector
Health Technology
Industry
Medical Specialties
CEO
Michael F. Mahoney
Website
bostonscientific.com
Headquarters
Marlborough
Founded
1979
IPO date
May 19, 1992
ISIN
US1011371077
CUSIP
101137107
FIGI
BBG000C0LW92
Identifiers
ISIN US1011371077
CFI code
ESVUFR
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


5.833% YTM
Maturity dateMar 1, 2049
Coupon4.70% (Fixed)
5.571% YTM
Maturity dateJan 15, 2040
Coupon7.38% (Fixed)
5.481% YTM
Maturity dateMar 1, 2039
Coupon4.55% (Fixed)
5.179% YTM
Maturity dateNov 15, 2035
Coupon6.25% (Fixed)
4.759% YTM
Maturity dateJun 1, 2030
Coupon2.65% (Fixed)
4.433% YTM
Maturity dateMar 1, 2029
Coupon4.00% (Fixed)
4.354% YTM
Maturity dateMar 1, 2028
Coupon4.00% (Fixed)
3.855% YTM
Maturity dateMar 8, 2034
Coupon3.25% (Fixed)
3.818% YTM
Maturity dateMar 8, 2034
Coupon1.88% (Fixed)
3.609% YTM
Maturity dateMar 8, 2032
Coupon3.50% (Fixed)
3.500% YTM
Maturity dateMar 8, 2031
Coupon3.00% (Fixed)

See all BSX bonds 

ETFs holding the stock


VTI
Vanguard Morningstar Total Stock Market ETF
Weight0.09%
Market value‪2.01 B‬
VOO
Vanguard S&P 500 ETF
Weight0.10%
Market value‪1.65 B‬
IVV
iShares Core S&P 500 ETF
Weight0.11%
Market value‪991.46 M‬
SPY
SPDR S&P 500 ETF TRUST
Weight0.11%
Market value‪889.79 M‬
XLV
State Street Health Care Select Sector SPDR ETF
Weight1.24%
Market value‪530.57 M‬
VUG
Vanguard Morningstar Growth ETF
Weight0.10%
Market value‪392.71 M‬
VTV
Vanguard Morningstar Value ETF
Weight0.12%
Market value‪302.15 M‬
FCLC
Fidelity Canadian Large Cap Fund ETF Series ETF Trust Units
Weight2.45%
Market value‪230.11 M‬
VHT
Vanguard Health Care ETF
Weight0.93%
Market value‪190.68 M‬
RSP
Invesco S&P 500 Equal Weight ETF
Weight0.19%
Market value‪189.33 M‬
SPYM
State Street SPDR Portfolio S&P 500 ETF
Weight0.11%
Market value‪185.12 M‬

Explore more ETFs 

Frequently asked questions


The current price of BSX is 49.31 USD — it has increased by 0.13% in the past 24 hours. Watch Boston Scientific Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Boston Scientific Corporation stocks are traded under the ticker BSX.
BSX stock has risen by 7.69% compared to the previous week, the month change is a 10.44% rise, over the last year Boston Scientific Corporation has showed a −52.29% decrease.
We've gathered analysts' opinions on Boston Scientific Corporation future price: according to them, BSX price has a max estimate of 85.00 USD and a min estimate of 44.00 USD. Watch BSX chart and read a more detailed Boston Scientific Corporation stock forecast: see what analysts think of Boston Scientific Corporation and suggest that you do with its stocks.
BSX reached its all-time high on Sep 9, 2025 with the price of 109.50 USD, and its all-time low was 2.34 USD and was reached on Oct 7, 1993. View more price dynamics on BSX chart.
See other stocks reaching their highest and lowest prices.
BSX stock is 2.16% volatile and has beta coefficient of 0.31. Track Boston Scientific Corporation stock price on the chart and check out the list of the most volatile stocks — is Boston Scientific Corporation there?
Today Boston Scientific Corporation has the market capitalization of ‪71.46 B‬, it has increased by 7.19% over the last week.
Yes, you can track Boston Scientific Corporation financials in yearly and quarterly reports right on TradingView.
Boston Scientific Corporation is going to release the next earnings report on Oct 28, 2026. Keep track of upcoming events with our Earnings Calendar.
BSX earnings for the last quarter are 0.86 USD per share, whereas the estimation was 0.84 USD resulting in a 2.94% surprise. The estimated earnings for the next quarter are 0.81 USD per share. See more details about Boston Scientific Corporation earnings.
Boston Scientific Corporation revenue for the last quarter amounts to ‪5.44 B‬ USD, despite the estimated figure of ‪5.38 B‬ USD. In the next quarter, revenue is expected to reach ‪5.26 B‬ USD.
BSX net income for the last quarter is ‪907.00 M‬ USD, while the quarter before that showed ‪1.34 B‬ USD of net income which accounts for 0.00% change. Track more Boston Scientific Corporation financial stats to get the full picture.
No, BSX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 8, 2026, the company has ‪59 K‬ employees. See our rating of the largest employees — is Boston Scientific Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Boston Scientific Corporation EBITDA is ‪5.99 B‬ USD, and current EBITDA margin is 27.09%. See more stats in Boston Scientific Corporation financial statements.
Like other stocks, BSX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Boston Scientific Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Boston Scientific Corporation technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Boston Scientific Corporation stock shows the sell signal. See more of Boston Scientific Corporation technicals for a more comprehensive analysis.